Abstract:Background: There are many uncertainties concerning variations in benzo[a]pyrene (B[a]P) soil guidelines protecting human health based on carcinogenic data obtained in animal studies. Although swine is recognised as being much more representative of the human child in terms of body size, gut physiology and genetic profile the rat/mice model is commonly used in practice. Objectives: We compare B[a]P bioavailability using a rat model to that estimated in a swine model, to investigate the correlation between these two animal models. This may help reduce uncertainty in applying bioavailability to human health risk assessment. Methods: Twelve spiked soil samples and a spiked silica sand (reference material) were dosed to rats in parallel with a swine study. B[a]P bioavailability was estimated by the area under the plasma B[a]P concentration-time curve (AUC) and faecal excretion as well in the rats. Direct comparison between the two animal models was made for: firstly, relative bioavailability (RB) using AUC assay; and secondly, the two assays in the rat model. Results: Both AUC and faecal excretion assays showed linear dose-response for the reference material. However, absolute bioavailability was significantly higher when using faecal excretion assay (p<0.001). In aged soils faecal excretion estimated based on solvent extraction was not accurate due to the form of non-extractable fraction through ageing. A significant correlation existed between the two models using RB for soil samples (RBrat=0.26RBswine+17.3, R(2)=0.70, p<0.001), despite the regression slope coefficient revealing that the rat model would underestimate RB by about one quarter compared to using swine. Conclusions: In the comparison employed in this study, an interspecies difference of four in RB using AUC assay was identified between the rat and swine models regarding pharmacokinetic differences, which supported the body weight scaling method recommended by US EPA. Future research should focus on the carcinogenic competency (pharmacodynamics) used in experiment animals and humans.

Lead Relative Bioavailability in Soils Based on Different Endpoints of a Mouse Model.

Arsenic Relative Bioavailability in Contaminated Soils: Comparison of Animal Models, Dosing Schemes, and Biological End Points

Comparison of in Vitro Models in a Mice Model and Investigation of the Changes in Pb Speciation During Pb Bioavailability Assessments.

An Interlaboratory Evaluation of the Variability in Arsenic and Lead Relative Bioavailability when Assessed Using a Mouse Bioassay.

Lead bioaccessibility in 12 contaminated soils from China: Correlation to lead relative bioavailability and lead in different fractions.

As, Cd, and Pb Relative Bioavailability in Contaminated Soils: Coupling Mouse Bioassay with UBM Assay.

Lead Bioavailability in Different Fractions of Mining- and Smelting-Contaminated Soils Based on a Sequential Extraction and Mouse Kidney Model

Using the SBRC Assay to Predict Lead Relative Bioavailability in Urban Soils: Contaminant Source and Correlation Model.

Food Influence on Lead Relative Bioavailability in Contaminated Soils: Mechanisms and Health Implications.

Assessment of in Vitro Lead Bioaccessibility in House Dust and Its Relationship to in Vivo Lead Relative Bioavailability.

Variation of lead bioaccessibility in soil reference materials: Intra- and inter-laboratory assessments

Effect of Phosphate Amendment on Relative Bioavailability and Bioaccessibility of Lead and Arsenic in Contaminated Soils.

Investigating Lead Species and Bioavailability in Contaminated Soils: Coupling DGT Technique with Artificial Gastrointestinal Extraction and in Vivo Bioassay.

Assessment of Cadmium Bioaccessibility to Predict Its Bioavailability in Contaminated Soils

Antagonistic Interactions Between Arsenic, Lead, and Cadmium in the Mouse Gastrointestinal Tract and Their Influences on Metal Relative Bioavailability in Contaminated Soils.

Evaluating the mouse model for estimation of arsenic bioavailability: Comparison of estimates of absolute bioavailability of inorganic arsenic in mouse, humans, and other species

Comparison of oral bioavailability of benzo[a]pyrene in soils using rat and swine and the implications for human health risk assessment

Influence of soil pH and organic carbon content on the bioaccessibility of lead and copper in four spiked soils

In Vitro Bioaccessibility and in Vivo Relative Bioavailability in 12 Contaminated Soils: Method Comparison and Method Development

Nickel oral bioavailability in contaminated soils using a mouse urinary excretion bioassay: Variation with bioaccessibility

Effect of soluble phosphate and bentonite amendments on lead and cadmium bioavailability and bioaccessibility in a contaminated soil